Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP6 | P55212 | 1/20 | 0.70 |
| ▸ | TSHR | P16473 | 2/20 | 0.64 |
| ▸ | LMNA | P02545 | 2/20 | 0.64 |
| ▸ | HCAR3 | P49019 | 8/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.56 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.56 |
| ▸ | APEX1 | P27695 | 1/20 | 0.54 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6827373 | 0.88 | HCAR3 (0.58) | CASP6TSHRLMNAHCAR3ALDH1A1 | |
| SCHEMBL4605109 | 0.87 | VCAM1 (0.62) | CASP6TSHRLMNAALDH1A1HIF1A | |
| SCHEMBL6704718 | 0.86 | ERN1 (0.56) | CASP6TSHRLMNAALDH1A1HIF1A | |
| SCHEMBL6238 | 0.85 | CASP6 (0.70) | CASP6TSHRLMNAHCAR3APEX1 | |
| SCHEMBL30001328 | 0.85 | CASP6 (0.70) | CASP6TSHRLMNAHCAR3APEX1 | |
| SCHEMBL8626465 | 0.85 | TTR (0.62) | CASP6TSHRLMNAALDH1A1HIF1A | |
| Acetic Acid SCHEMBL28375520 | 0.84 | MAPT (0.55) | CASP6TSHRLMNAHCAR3ALDH1A1 | |
| SCHEMBL3476754 | 0.84 | PARP1 (0.65) | CASP6TSHRLMNAALDH1A1HIF1A | |
| Hydrochloric Acid SCHEMBL5568198 | 0.84 | CASP6 (0.68) | CASP6TSHRLMNAHCAR3APEX1 | |
| SCHEMBL9157 | 0.84 | ITGB1 (0.57) | CASP6TSHRLMNAALDH1A1HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1981 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4127157-B1 | MODIFIED DIPEPTIDE CLEAVASES, USES THEREOF AND RELATED KITS | ENCODIA INC (US) | 2026-02-11 | — | — | EP | claimed |
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| CN-118812209-A | Preparation method of polyvinyl alcohol emulsion modified cement paste generated in situ | 海南大学 | 2024-10-22 | — | — | CN | claimed |
| CN-118621569-A | Polyvinyl alcohol fiber surface acetalation modification method | 海南大学 | 2024-09-10 | — | — | CN | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| CN-118184679-A | Photothermal agent and preparation method thereof, photothermal nanoparticle and preparation method thereof, insulating material and self-repairing method of insulating material | 中国石油天然气股份有限公司 | 2024-06-14 | — | — | CN | claimed |
| US-20240011009-A1 | MODIFIED DIPEPTIDE CLEAVASES, USES THEREOF AND RELATED KITS | Encodia, Inc. (US) | 2024-01-11 | — | — | US | claimed |
| US-20230220589-A1 | POLYPEPTIDE TERMINAL BINDERS AND USES THEREOF | Encodia, Inc. (US) | 2023-07-13 | — | — | US | claimed |
| EP-4127157-A1 | MODIFIED DIPEPTIDE CLEAVASES, USES THEREOF AND RELATED KITS | Encodia, Inc. (US) | 2023-02-08 | — | — | EP | claimed |
| WO-2022072560-A1 | POLYPEPTIDE TERMINAL BINDERS AND USES THEREOF | Encodia, Inc. (US) | 2022-04-07 | — | — | WO | claimed |
| EP-1217884-B1 | METHOD FOR MATURATION OF CONIFER SOMATIC EMBRYOS | WOODY PLANT BIOTECH APS (DK) | 2007-02-21 | — | — | EP | claimed |
| US-7033424-B2 | Phase change inks | XEROX CORPORATION (US) | 2006-04-25 | — | — | US | claimed |
| US-20060021546-A1 | Processes for preparing phase change inks | XEROX CORPORATION | 2006-02-02 | — | — | US | claimed |
| US-20060020141-A1 | Metallized dye | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20060016369-A1 | PHASE CHANGE INKS | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-6946025-B2 | Process for preparing tetra-amide compounds | XEROX CORPORATION (US) | 2005-09-20 | — | — | US | claimed |
| US-6897065-B1 | Method for maturation of conifer somatic embryos | WOODY PLANT BIOTECH APS (DK) | 2005-05-24 | — | — | US | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
| EP-1217884-A1 | METHOD FOR MATURATION OF CONIFER SOMATIC EMBRYOS | Woody Plant Biotech APS (DK) | 2002-07-03 | — | — | EP | claimed |
| WO-2001020972-A1 | METHOD FOR MATURATION OF CONIFER SOMATIC EMBRYOS | WOODY PLANT BIOTECH APS (DK) | 2001-03-29 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060020141-A1 | Metallized dye | CDYL, CDY1; CDY1B, CDYL2 | CASP6 2660/4885TSHR 2894/4885LMNA 1769/4885 |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | CASP6 2761/4885TSHR 4082/4885LMNA 2024/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.